Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?

10 Dec 2019

Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business.

Sanofi plans to operate its Consumer Healthcare unit as a standalone business in a move which is being viewed as a prelude to a potential spin-off.

The French pharma giant’s CEO Paul Hudson – who took the reins in September – outlined his ambition to shake-up...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

14 Jul 2025

• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

07 Jul 2025

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

04 Jul 2025

• By Tom Gallen

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

Haleon Takes Full Control Of China JV

02 Jul 2025

• By Tom Gallen

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."